Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-01 Sale |
2022-02-03 5:31 pm |
Syndax Pharmaceuticals Inc | SNDX | Nolte Alexander Chief Accounting Officer |
968 | $16.65 | $16,117 | 30,968 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-02 Option Award |
2023-02-03 4:58 pm |
N/A 2033-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Nolte Alexander Chief Accounting Officer |
17,000 | $28.55 | 17,000 (Direct) |
View |
| 2022-01-31 Other |
2022-02-03 5:31 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Nolte Alexander Chief Accounting Officer |
968 | $12.39 | 30,968 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-03 5:31 pm |
N/A 2032-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Nolte Alexander Chief Accounting Officer |
30,000 | $15.79 | 30,968 (Direct) |
View |
Ownership |
2021-11-04 4:03 pm |
N/A 2031-02-03 |
Syndax Pharmaceuticals Inc | SNDX | Nolte Alexander Chief Accounting Officer |
0 | $0 | 156,667 (Direct) |
View |